G. Nedellec

Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

Philippe Moreau, Véronique Leblond, Priscille Bourquelot et al. · British Journal of Haematology · 1998 · 229 citations · Full text

Medicine, Nephrology, Cell Therapy +13

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group

Michel Attal, Didier Blaise, Gérald Marit et al. · Blood · 1995 · 159 citations · Full text

Medicine, Hematology, Oncology +12

Comparison of High-Dose Therapy and Autologous Stem-Cell Transplantation With Conventional Therapy for Hodgkin's Disease Induction Failure: A Case-Control Study

Marc André, M. Henry‐Amar, José-Luis Pico et al. · Journal of Clinical Oncology · 1999 · 154 citations

Medicine, Hematology, Oncology +15

Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.

Marc André, M. Henry‐Amar, Didier Blaise et al. · PubMed · 1998 · 140 citations

Medicine, Oncology, Cell Therapy +14

The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin’s disease

Christophe Fermé, Y Bastion, Éric Lepage et al. · Annals of Oncology · 1995 · 124 citations · Full text

Medicine, Oncology, Chemotherapy +11